首页> 中文期刊> 《中华医学杂志(英文版)》 >Pneumonia relevant to lung transplantation and pathogen distribution

Pneumonia relevant to lung transplantation and pathogen distribution

         

摘要

Background Pneumonia is the most common cause of morbidity and mortality in lung transplant (LT) recipients.The aim of the present study was to evaluate the incidence,etiology,risk factors and prognosis of pneumonia in LT recipients.Methods The LT cohort consisted of 28 recipients receiving LT in Beijing Chao-Yang Hospital from August 2005 to April 2011.Data collected included demographic data,underlying disorders,time and type of transplant,follow-up information,date of last follow-up,and patient status.A retrospective analysis was made of observational data that were prospectively collected.Results Twenty-two patients of 28 LT recipients had 47 episodes of pneumonia throughout the study period.Thirtyeight episodes of pneumonia in 19 recipients occurred post-LT with a median follow-up of 257.5 days (1-2104 days),the incidence of pneumonia was 192.4 episodes per 100 LT/year and its median time of onset was 100.5 days (0-946 days) post-transplantation.Bacteria,virus and fungi accounted for 62%,16% and 15% of the microbial pathogens,respectively.The most frequent were Pseudomonas aeruginosa (20%),cytomegalovirus (CMV) (15%),and Aspergillus fumigatus (10%).A total of 29% (11/38) of pneumonias occurred in the first month post-LT,and then the incidence decreased gradually.The incidence of CMV pneumonia was 25% (7/28) with a median time of 97 days (10-971 days).More than one bacterial infection and CMV infection were independent risk factors for aspergillus infection.The incidence of pulmonary tuberculosis (TB) was 18% (5/28),and the history of TB was a risk factor for TB relapse.There were 58% (7/12) of recipients who died of infection,and 71% (5/7) of these died in the first year after LT.Conclusions Pneumonia is still a major cause of morbidity and mortality in LT recipients.The most frequent microorganisms were Pseudomonas aeruginosa,CMV,and Aspergillus fumigates.The incidence of CMV pneumonia decreases with a delayed median time of onset.More than one incidence of bacterial infection and CMV infection are independent risk factors for aspergillus infection.LT recipients are at high risk for TB,and the history of TB is a risk factor for TB relapse.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2013年第17期|3209-3214|共6页
  • 作者单位

    Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Thoracic Surgery,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Thoracic Surgery,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Image,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

    Department of Thoracic Surgery,Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China;

    Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine, Beijing 100020, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号